Lawmakers are poised to throw former President Donald Trump’s belated bid to lower Medicare drug prices under the bus.

Michael McAuliff | Kaiser Health News
Senator: $3.5T budget may have to trim but it can set a path to ‘ambitious goals’
Senator negotiating health-related provisions hopes for a complete health care system for older Americans and significantly reduced costs for everyone.
Drugmakers’ spending on stock, dividends and executive pay exceeds research, Democrats say
The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday that argues the industry can afford to charge Medicare less for prescriptions. The report by the House Oversight and Reform Committee says that contrary to pharmaceutical industry arguments that […]
Buried in opioid bill — protection for personal drug imports
WASHINGTON — The final version of the massive opioid bill Congress released Wednesday would grant the Food and Drug Administration new powers to crack down on drug imports, but it also includes a provision — nearly killed in the Senate — to shield people who are just trying to buy cheaper, needed prescription medication from other countries.
McConnell has about $200B in ‘candy’ to sweeten Obamacare repeal
WASHINGTON — The path to 50 votes for an Obamacare replacement bill seemed to narrow dramatically Thursday as efforts to craft a quick compromise foundered — but Senate Majority Leader Mitch McConnell has $200 billion to build a bridge to victory. His dealmaking may be just beginning.